AVE 25.0% 0.3¢ avecho biotechnology limited

whats wrong ?, page-5

  1. 202 Posts.
    It looks like they are using a sales facility to sell new shareholders shares (from looking at announcements).

    8 million traded the other day may have been the sales facility shares sold to an institutional investor?

    Looks like gearing after the merger has improved (from announcements), and net assets (property) are over $2/share so could be good buying once they start heading north again

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.